ILTREX

Welcome to the Brand page for “ILTREX”, which is offered here for Molecular biologically developed medicines, serums, therapeutic preparations for animals and humans for the treatment of cardiac diseases, skin diseases, cancer,diabetes and obesity; molecular biologically developed test kits for clinical and medical laboratory use, comprised of biochemical and biotechnological components for the identification, analysis and validation of target genes and/or the identification of new pharmaceutically active compounds for human medical and veterinary medical diagnostic and therapy purposes; and molecular biologically developed diagnostic preparations for clinical and medical laboratory use;.

Its status is currently believed to be active. Its class is unavailable. “ILTREX” is believed to be currently owned by “MEDIGENE AG”.


Owner:
MEDIGENE AG
Owner Details
Description:
MOLECULAR BIOLOGICALLY DEVELOPED MEDICINES, SERUMS, THERAPEUTIC PREPARATIONS FOR ANIMALS AND HUMANS FOR THE TREATMENT OF CARDIAC DISEASES, SKIN DISEASES, CANCER,DIABETES AND OBESITY; MOLECULAR BIOLOGICALLY DEVELOPED TEST KITS FOR CLINICAL AND MEDICAL LABORATORY USE, COMPRISED OF BIOCHEMICAL AND BIOTECHNOLOGICAL COMPONENTS FOR THE IDENTIFICATION, ANALYSIS AND VALIDATION OF TARGET GENES AND/OR THE IDENTIFICATION OF NEW PHARMACEUTICALLY ACTIVE COMPOUNDS FOR HUMAN MEDICAL AND VETERINARY MEDICAL DIAGNOSTIC AND THERAPY PURPOSES; AND MOLECULAR BIOLOGICALLY DEVELOPED DIAGNOSTIC PREPARATIONS FOR CLINICAL AND MEDICAL LABORATORY USE;
Categories: MOLECULAR BIOLOGICALLY DEVELOPED MEDICINES